FNEL to acquire 100% stake in Albert Pharma

November 06, 2025 (MLN): The Board of Directors of First National Equities Limited (FNEL), in an emergent meeting held on Thursday, granted in-principle approval for the proposed acquisition of 100% equity interest in Albert Pharma (Private) Limited. 

This was shared by the company through an official notification to the Pakistan Stock Exchange (PSX). 

The acquisition remains subject to completion of due diligence, execution of definitive agreements, and fulfilment of all applicable regulatory requirements.

In line with the authorization granted by shareholders during the company’s Annual General Meeting (AGM) on October 28, 2025, the Board has also instructed the CEO and Company Secretary to develop a comprehensive Shariah-compliant business and financial plan in accordance with SECP and PSX regulations.

The proposed plan will outline FNEL’s strategic shift toward diversification, aiming to gradually expand beyond its traditional stock brokerage business into the pharmaceuticals, healthcare, and allied sectors as its new core operations.

Additionally, the plan will address legal and regulatory frameworks to ensure a seamless transition and compliance with all requirements, with the objective of achieving long-term value creation for shareholders.

The company stated that this disclosure has been made to ensure regulatory compliance and to keep market participants duly informed.

Copyright Mettis Link News